BSX Deferred Revenue
Boston Scientific · Deferred Revenue
BSX Deferred Revenue
Latest reported$313.00Mperiod ending
BSX FY Deferred Revenue ($0.00 → $313.00M)
Annual deferred revenue
High-resolution chart · PNG
BSX deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 313,000,000 | |
| 306,000,000 | |
| 266,000,000 | |
| 220,000,000 | |
| 208,000,000 | |
| 138,000,000 | |
| 144,000,000 | |
| 328,000,000 | |
| 191,000,000 | |
| 75,000,000 | |
| 496,000,000 | |
| 447,000,000 | |
| 288,000,000 | |
| 433,000,000 | |
| 458,000,000 | |
| 429,000,000 | |
| 572,000,000 | |
| 911,000,000 | |
| 679,000,000 | |
| 583,000,000 | |
| 152,000,000 | |
| 902,000,000 | |
| 597,000,000 | |
| 639,000,000 | |
| 421,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |